Lofty, M., et al. Biological activity of bee propolis in health and disease. Asian Pacific Journal of Cancer Prevention 2006. Vol 7 22-31.
Aga, H., et al. Isolation and identification of antimicrobial compounds in Brazilian propolis. Bioscience Biotechnology and Biochemistry 1994. 58, 945-6.
Marquez, N., et al. Caffeic acid phenethyl ester inhibits T cell activation by targeting both nuclear factor of activated T cells and NF-kB transcription factors. J Pharmacol Exp Ther (JPET) 2004. 308,993-1001.
Grange, J.M., et al. Antibacterial properties of propolis. J Royal Society of Med 1990. 83, 159-160.
De Almeida, et al. Anti-inflammatory activity of propolis extracts: A review. J Venom Anim Toxins 2002. 8, 191-212.
Liao, H.F., et al. Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumour invasion and metastasis. J Agric Food Chem 2003. 51, 7907-12.
Luo, J., et al. PM-3, a benzo-gamma-pyran derivative isolated from propolis, inhibits the growth of MCF-7 human breast cancer cells. Anticancer Res 2001, 21, 1665-71.
Lahouel, M., et al. The flavonoids effect against vinblastine, cyclophosphamide and paracetamol toxicity by inhibition of lipid peroxidation and increasing liver glutathione concentrations. Pathol Biol 2004. 52,314-22.